Dr. Singer of the Cato Institute discusses trends in drug policy

Dr. Jeffrey Singer is a senior fellow at the Cato Institute and works in the Department of Health Policy Studies. He is a nationally recognized thought leader in health policy, particularly the harmful effects of drug prohibition. He has written extensively about the importance of harm reduction and follows national and state policy closely. The JAMA article cited during the podcast that questions the legitimacy of MME (Morphine Milligram Equivalents) is in the following link: https://jamanetwork.com/journals/jama/article-abstract/358674 #prohibition #drugs #overdose #fentanyl #carfentanil #nitazene #xylazine